| Aha/asa guideline WJ Powers, CP Derdeyn, J Biller, CS Coffey, BL Hoh, EC Jauch, ... Stroke 46 (10), 3020-35, 2015 | 2559* | 2015 |
| 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding … WJ Powers, CP Derdeyn, J Biller, CS Coffey, BL Hoh, EC Jauch, ... Stroke 46 (10), 3020-3035, 2015 | 1587 | 2015 |
| Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial KC Johnston, JY Li, PD Lyden, SK Hanson, TE Feasby, RJ Adams, ... Stroke 29 (2), 447-453, 1998 | 619 | 1998 |
| Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial KC Johnston, A Bruno, Q Pauls, CE Hall, KM Barrett, W Barsan, A Fansler, ... Jama 322 (4), 326-335, 2019 | 361 | 2019 |
| Phase IIB/III trial of tenecteplase in acute ischemic stroke: results of a prematurely terminated randomized clinical trial EC Haley Jr, JLP Thompson, JC Grotta, PD Lyden, TG Hemmen, ... Stroke 41 (4), 707-711, 2010 | 324 | 2010 |
| Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the … BM Coull, LS Williams, LB Goldstein, JF Meschia, D Heitzman, ... Stroke 33 (7), 1934-1942, 2002 | 313 | 2002 |
| Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials JL Saver, KC Johnston, D Homer, R Wityk, W Koroshetz, LL Truskowski, ... Stroke 30 (2), 293-298, 1999 | 310 | 1999 |
| A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke EC Haley Jr, PD Lyden, KC Johnston, TM Hemmen, ... Stroke 36 (3), 607-612, 2005 | 288 | 2005 |
| A predictive risk model for outcomes of ischemic stroke KC Johnston, AF Connors Jr, DP Wagner, WA Knaus, XQ Wang, ... Stroke 31 (2), 448-455, 2000 | 282 | 2000 |
| A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS) P Scott, W Barsan, S Frederiksen, S Kronick, BJ Zink, RM Domeier, ... Stroke (1970) 27 (9), 1453-1458, 1996 | 254 | 1996 |
| Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke P Khatri, MR Conaway, KC Johnston, ... Stroke 43 (2), 560-562, 2012 | 221 | 2012 |
| Stroke Therapy Academic Industry Roundtable (STAIR) recommendations for extended window acute stroke therapy trials JL Saver, GW Albers, B Dunn, KC Johnston, M Fisher Stroke 40 (7), 2594-2600, 2009 | 197 | 2009 |
| Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial KC Johnston, CE Hall, BM Kissela, TP Bleck, MR Conaway Stroke 40 (12), 3804-3809, 2009 | 196 | 2009 |
| Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke DL Brown, KC Johnston, DP Wagner, EC Haley Jr Stroke 35 (1), 147-150, 2004 | 183 | 2004 |
| Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke SN Chapman, P Mehndiratta, MC Johansen, TL McMurry, KC Johnston, ... Vascular health and risk management, 75-87, 2014 | 182 | 2014 |
| Standardizing the structure of stroke clinical and epidemiologic research data: the National Institute of Neurological Disorders and Stroke (NINDS) Stroke Common Data Element … JL Saver, S Warach, S Janis, J Odenkirchen, K Becker, O Benavente, ... Stroke 43 (4), 967-973, 2012 | 158 | 2012 |
| Translational stroke research: vision and opportunities F Bosetti, JI Koenig, C Ayata, SA Back, K Becker, JP Broderick, ... Stroke 48 (9), 2632-2637, 2017 | 143 | 2017 |
| Levels of evidence: taking RA Gross, KC Johnston Neurology, 8-10, 0 | 137 | |
| Readmissions after cardiac surgery: experience of the National Institutes of Health/Canadian Institutes of Health research cardiothoracic surgical trials network A Iribarne, H Chang, JH Alexander, AM Gillinov, E Moquete, JD Puskas, ... The Annals of thoracic surgery 98 (4), 1274-1280, 2014 | 135 | 2014 |
| Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? KC Johnston, DP Wagner, XQ Wang, GC Newman, V Thijs, S Sen, ... Stroke 38 (6), 1820-1825, 2007 | 131 | 2007 |
S. Claiborne JohnstonDean, Dell Medical School, University of Texas, AustinПодтвержден адрес электронной почты в домене utexas.edu
